1. Home
  2. PEN vs WAL Comparison

PEN vs WAL Comparison

Compare PEN & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • WAL
  • Stock Information
  • Founded
  • PEN 2004
  • WAL 1994
  • Country
  • PEN United States
  • WAL United States
  • Employees
  • PEN N/A
  • WAL N/A
  • Industry
  • PEN Medical/Dental Instruments
  • WAL Major Banks
  • Sector
  • PEN Health Care
  • WAL Finance
  • Exchange
  • PEN Nasdaq
  • WAL Nasdaq
  • Market Cap
  • PEN 11.1B
  • WAL 9.3B
  • IPO Year
  • PEN 2015
  • WAL 2005
  • Fundamental
  • Price
  • PEN $267.51
  • WAL $76.11
  • Analyst Decision
  • PEN Strong Buy
  • WAL Strong Buy
  • Analyst Count
  • PEN 16
  • WAL 15
  • Target Price
  • PEN $291.60
  • WAL $98.07
  • AVG Volume (30 Days)
  • PEN 413.7K
  • WAL 1.1M
  • Earning Date
  • PEN 05-06-2025
  • WAL 04-17-2025
  • Dividend Yield
  • PEN N/A
  • WAL 2.00%
  • EPS Growth
  • PEN N/A
  • WAL 8.41
  • EPS
  • PEN 0.36
  • WAL 7.09
  • Revenue
  • PEN $1,194,615,000.00
  • WAL $3,016,200,000.00
  • Revenue This Year
  • PEN $14.26
  • WAL $13.49
  • Revenue Next Year
  • PEN $14.29
  • WAL $10.02
  • P/E Ratio
  • PEN $733.61
  • WAL $10.74
  • Revenue Growth
  • PEN 12.86
  • WAL 17.96
  • 52 Week Low
  • PEN $148.00
  • WAL $53.75
  • 52 Week High
  • PEN $310.00
  • WAL $98.10
  • Technical
  • Relative Strength Index (RSI)
  • PEN 44.19
  • WAL 40.46
  • Support Level
  • PEN $273.00
  • WAL $75.24
  • Resistance Level
  • PEN $288.57
  • WAL $81.94
  • Average True Range (ATR)
  • PEN 8.21
  • WAL 2.48
  • MACD
  • PEN -0.93
  • WAL 0.46
  • Stochastic Oscillator
  • PEN 38.19
  • WAL 43.73

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: